Opinion|Videos|August 28, 2024
Early Diagnosis and Treatment for Central Precocious Puberty
The panel explores the impact of early versus delayed diagnosis and treatment initiation on long-term outcomes in Central Precocious Puberty patients.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- How might an early CPP diagnosis and subsequent treatment initiation affect outcomes, compared to a later start?
Advertisement
Related to this article
Researchers discuss how testosterone changes during early puberty may influence depression and anxiety symptoms in girls and implications for pediatricians.
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study.
In a meta-analysis of 46 RCTs, behavioral interventions modestly improved HbA1c in youth with T1D; family-focused approaches worked best.
Nationwide Children's experts urge early screening and family-based lifestyle change as youth-onset T2D progresses faster than adult disease.
Advertisement
Advertisement